PMID:18084243: Difference between revisions

From EcoliWiki
Jump to navigation Jump to search
/Volumes/r3/t3/ul/working/touchTables/touch_all_tables.php
imported>Wikientrybot
change PMID template to TableEdit version
Line 1: Line 1:
{{RightTOC}}
{{RightTOC}}
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.130145.V52238ec79aa9a-->
<!--
******************************************************************************************
*
*  ** PLEASE DON'T EDIT THIS TABLE DIRECTLY.  Use the edit table link under the table. **
*
****************************************************************************************** -->
{|  id="V52238ec79aa9a"  class=" tableEdit PMID_info_table" 


<span style = 'font-size: large'> '''Fensterle, J, Bergmann, B, Yone, CL, Hotz, C, Meyer, SR, Spreng, S, Goebel, W, Rapp, UR and Gentschev, I'''  (2008) Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B.''Cancer Gene Ther.'' '''15''':85-93</span>
{|{{Prettytable}} align = 'center' width= '70%'
|-
|-
|{{TableHeadingColor}} |'''Abstract''' || Prostate cancer is the most common malignant tumor in men and is normally associated with increased serum levels of prostate-specific antigen (PSA). Therefore, PSA is one potential target for a prostate cancer vaccine. In this study we analyzed the functionality of new bacterial PSA vaccines, expressed and secreted via the hemolysin (HlyA) secretion system of Escherichia coli, the prototype of Type I secretion systems (T1SS) using an attenuated Salmonella enterica serovar Typhimurium aroA strain as carrier. The data demonstrate that a bacterial live vaccine encompassing T1SS in combination with cholera toxin subunit B can be successfully used for delivery of PSA to induce cytotoxic CD8+ T-cell responses resulting in an efficient prevention of tumor growth in mice.
!align=left  |Citation
</noinclude>
||
'''No author listed'''  (2008) Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B. ''Cancer Gene Ther.'' '''15''':85-93
|-
!align=left  |Abstract
||
Prostate cancer is the most common malignant tumor in men and is normally associated with increased serum levels of prostate-specific antigen (PSA). Therefore, PSA is one potential target for a prostate cancer vaccine. In this study we analyzed the functionality of new bacterial PSA vaccines, expressed and secreted via the hemolysin (HlyA) secretion system of Escherichia coli, the prototype of Type I secretion systems (T1SS) using an attenuated Salmonella enterica serovar Typhimurium aroA strain as carrier. The data demonstrate that a bacterial live vaccine encompassing T1SS in combination with cholera toxin subunit B can be successfully used for delivery of PSA to induce cytotoxic CD8+ T-cell responses resulting in an efficient prevention of tumor growth in mice.
|-
!align=left  |Links
||
[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=18084243 PubMed]
Online version:[http://dx.doi.org/10.1038/sj.cgt.7701109 10.1038/sj.cgt.7701109]
|-
|-
|{{TableHeadingColor}} nowrap |'''Links''' ||  [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=18084243 PubMed]
!align=left  |Keywords
||
Animals; Cancer Vaccines/genetics; Cancer Vaccines/immunology; Cancer Vaccines/therapeutic use; Cholera Toxin/genetics; Cholera Toxin/immunology; Cholera Toxin/secretion; Escherichia coli Proteins/genetics; Escherichia coli Proteins/secretion; Female; Hemolysin Proteins/genetics; Hemolysin Proteins/secretion; Humans; Immunotherapy, Active; Male; Mice; Mice, Inbred DBA; Prostate-Specific Antigen/genetics; Prostate-Specific Antigen/immunology; Prostate-Specific Antigen/secretion; Prostatic Neoplasms/immunology; Prostatic Neoplasms/prevention & control; Salmonella Vaccines/genetics; Salmonella Vaccines/immunology; Salmonella Vaccines/therapeutic use; Salmonella typhimurium/genetics; Salmonella typhimurium/immunology; Typhoid-Paratyphoid Vaccines/genetics; Typhoid-Paratyphoid Vaccines/immunology; Typhoid-Paratyphoid Vaccines/therapeutic use; Vaccines, Attenuated/genetics; Vaccines, Attenuated/immunology; Vaccines, Synthetic/genetics; Vaccines, Synthetic/immunology
 
|- class="tableEdit_footer"
|<span class="tableEdit_editLink plainlinks">[{{SERVER}}{{SCRIPTPATH}}?title=Special:TableEdit&id=d41d8cd98f00b204e9800998ecf8427e.130145.V52238ec79aa9a&page=130145&pagename={{FULLPAGENAMEE}}&type=1&template=PMID_info_table edit table]</span> ||
|}
|}
 
<!--box uid=d41d8cd98f00b204e9800998ecf8427e.130145.V52238ec79aa9a-->
==Significance {{HelpIcon|Help:Literature}} ==
==Significance {{HelpIcon|Help:Literature}} ==
{{LitSignificance}}
{{LitSignificance}}

Revision as of 19:00, 1 September 2013

Citation

No author listed (2008) Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B. Cancer Gene Ther. 15:85-93

Abstract

Prostate cancer is the most common malignant tumor in men and is normally associated with increased serum levels of prostate-specific antigen (PSA). Therefore, PSA is one potential target for a prostate cancer vaccine. In this study we analyzed the functionality of new bacterial PSA vaccines, expressed and secreted via the hemolysin (HlyA) secretion system of Escherichia coli, the prototype of Type I secretion systems (T1SS) using an attenuated Salmonella enterica serovar Typhimurium aroA strain as carrier. The data demonstrate that a bacterial live vaccine encompassing T1SS in combination with cholera toxin subunit B can be successfully used for delivery of PSA to induce cytotoxic CD8+ T-cell responses resulting in an efficient prevention of tumor growth in mice.

Links

PubMed Online version:10.1038/sj.cgt.7701109

Keywords

Animals; Cancer Vaccines/genetics; Cancer Vaccines/immunology; Cancer Vaccines/therapeutic use; Cholera Toxin/genetics; Cholera Toxin/immunology; Cholera Toxin/secretion; Escherichia coli Proteins/genetics; Escherichia coli Proteins/secretion; Female; Hemolysin Proteins/genetics; Hemolysin Proteins/secretion; Humans; Immunotherapy, Active; Male; Mice; Mice, Inbred DBA; Prostate-Specific Antigen/genetics; Prostate-Specific Antigen/immunology; Prostate-Specific Antigen/secretion; Prostatic Neoplasms/immunology; Prostatic Neoplasms/prevention & control; Salmonella Vaccines/genetics; Salmonella Vaccines/immunology; Salmonella Vaccines/therapeutic use; Salmonella typhimurium/genetics; Salmonella typhimurium/immunology; Typhoid-Paratyphoid Vaccines/genetics; Typhoid-Paratyphoid Vaccines/immunology; Typhoid-Paratyphoid Vaccines/therapeutic use; Vaccines, Attenuated/genetics; Vaccines, Attenuated/immunology; Vaccines, Synthetic/genetics; Vaccines, Synthetic/immunology

Significance

You can help EcoliWiki by summarizing why this paper is useful

Useful Materials and Methods

You can help Ecoliwiki by describing the useful materials (strains, plasmids, antibodies, etc) described in this paper.

Annotations

Gene product Qualifier GO ID GO term name Evidence Code with/from Aspect Notes Status

EcoliWiki Links

Add links to pages that link here (e.g. gene, product, method pages)

References

See Help:References for how to manage references in EcoliWiki.